charles river laboratories
(CRL:New York)

Executive Profile*

Background*

Mr. Robert J. Bertolini, Bob, serves as the President and Chief Financial Officer of Bausch & Lomb Incorporated. Mr. Bertolini served as the Chief Financial Officer and Executive Vice President at Merck & Co. Inc. Mr. Bertolini has an extensive experience in audit, financial controls and corporate governance. He served as a Senior Adviser to top management on financial and general business issues, including licensing and M&A transactions. Mr. Bertolini began his professional ... career at the former Coopers & Lybrand in 1983 and rose steadily through its professional ranks, serving blue-chip global clients in the pharmaceutical industry. Mr. Bertolini served as Executive Vice President and Chief Financial Officer of Schering-Plough Corporation from November 17, 2003 to 2009, where he worked hand-in-hand with the Chief Executive Officer in all aspects of transforming its operations. Mr. Bertolini built world-class finance and information technology functions and led business development and strategy. He had responsibility for key financial areas including tax, accounting and financial asset management, among other areas. He had responsibility for global information technology and business development. He spent 20 years at PriceWaterhouseCoopers. In his previous role at PricewaterhouseCoopers, Mr. Bertolini managed a global organization of 1,500 professionals and 150 partners serving the pharmaceutical industry and other health-related industries. He has been a Director of Actelion Ltd. since May 5, 2011. He has been a Director of Genzyme Corporation since December 8, 2009 and Charles River Laboratories International, Inc., since January 24, 2011. He serves as a Director of New Jersey Performing Arts Center Corporation. He is a Certified Public Accountant. Mr. Bertolini graduated with a B.A. degree in Economics from Rutgers University, the State University of New Jersey.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CRL:US	$44.39 USD	+0.04

COMPETITOR COMPENSATION